Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, L.-X.
Right arrow Articles by Hu, H.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, L.-X.
Right arrow Articles by Hu, H.-M.
[Cancer Research 65, 10569-10577, November 15, 2005]
© 2005 American Association for Cancer Research


Immunology

Interleukin-7-Dependent Expansion and Persistence of Melanoma-Specific T Cells in Lymphodepleted Mice Lead to Tumor Regression and Editing

Li-Xin Wang1,3,4, Rui Li1,3, Guojun Yang1,3, May Lim1,3, Aisling O'Hara1,3, Yiwei Chu1,3,5, Bernard A. Fox2,3, Nicholas P. Restifo6, Walter J. Urba3 and Hong-Ming Hu1,3

1 Laboratory of Cancer Immunobiology; 2 Laboratory of Molecular and Tumor Immunology; 3 Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon; 4 Department of Microbiology and Immunology, School of Medicine, Southeast University, Nanjing, Jiangsu; 5 Department of Immunology, Shanghai Medical School of Fudan University, Shanghai, China; and 6 National Cancer Institute, NIH, Bethesda, Maryland

Requests for reprints: Hong-Ming Hu, Laboratory of Cancer Immunobiology, Providence Portland Medical Center, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, 4805 Northeast Glisan Street, Portland, OR 97213. Phone: 503-215-6531; Fax: 503-215-6841; E-mail: hhu{at}providence.org.

Active-specific immunotherapy with dendritic cells loaded with peptide derived from the melanoma antigen, gp100, failed to mediate regression of established B16F10 melanoma in normal mice. Dendritic cell vaccination induced activation and subsequent deletion of adoptively transferred naive CD8+ T-cell receptor transgenic (pmel-1) T cells specific for gp100 in normal mice. In lymphodepleted mice, dendritic cell vaccination produced greater T-cell expansion, long-term persistence of memory T cells, and tumor regression. Most tumors that persisted in the presence of functional memory T cells had either lost or exhibited reduced expression of MHC class I or gp100 proteins. In contrast to other naive T cells, pmel-1 T cells adoptively transferred to lymphodepleted mice exhibited faster proliferation and a more differentiated phenotype after exposure to peptide-pulsed dendritic cells. Proliferation and persistence of pmel-1 T cells was highly dependent on interleukin-7 (IL-7) in irradiated mice, and IL-15 when IL-7 was neutralized, two critical homeostatic cytokines produced in response to the irradiation-induced lymphodepletion.




This article has been cited by other articles:


Home page
J. Exp. Med.Home page
C. Sportes, F. T. Hakim, S. A. Memon, H. Zhang, K. S. Chua, M. R. Brown, T. A. Fleisher, M. C. Krumlauf, R. R. Babb, C. K. Chow, et al.
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
J. Exp. Med., July 7, 2008; 205(7): 1701 - 1714.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. Goldberger, I. Volovitz, A. Machlenkin, E. Vadai, E. Tzehoval, and L. Eisenbach
Exuberated Numbers of Tumor-Specific T Cells Result in Tumor Escape
Cancer Res., May 1, 2008; 68(9): 3450 - 3457.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Suzuki, S. Ogawa, K. Tanabe, H. Tahara, R. Abe, and H. Kishimoto
Induction of Antitumor Immune Response by Homeostatic Proliferation and CD28 Signaling
J. Immunol., April 1, 2008; 180(7): 4596 - 4605.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. S. Miller, D. J. Weisdorf, L. J. Burns, A. Slungaard, J. E. Wagner, M. R. Verneris, S. Cooley, R. Wangen, S. K. Fautsch, R. Nicklow, et al.
Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone
Blood, October 1, 2007; 110(7): 2761 - 2763.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. M. Paulos, A. Kaiser, C. Wrzesinski, C. S. Hinrichs, L. Cassard, A. Boni, P. Muranski, L. Sanchez-Perez, D. C. Palmer, Z. Yu, et al.
Toll-like Receptors in Tumor Immunotherapy
Clin. Cancer Res., September 15, 2007; 13(18): 5280 - 5289.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. M. Wall, K. Milne, M. L. Martin, P. H. Watson, P. Theiss, and B. H. Nelson
Spontaneous Mammary Tumors Differ Widely in Their Inherent Sensitivity to Adoptively Transferred T Cells
Cancer Res., July 1, 2007; 67(13): 6442 - 6450.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
X. Yang, Y. Chu, Y. Wang, R. Zhang, and S. Xiong
Targeted in vivo expression of IFN-{gamma}-inducible protein 10 induces specific antitumor activity
J. Leukoc. Biol., December 1, 2006; 80(6): 1434 - 1444.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.